The US FDA is likely to begin inspection at Jubilant Pharmova's Roorkee plant from March 2, sources told CNBC-TV18.
The US FDA had classified the plant as an Official Action Indicated (OAI) in December 2018 after inspection in August 2018.
The Roorkee plant is important for Jubilant Pharmova as it manufacture oral solid dosages which is around 20 percent of their total sales. So, it is an important plant for supplying to the US and other markets.
Watch video for more.